The Pediatric Growth Hormone Deficiency market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize the Pediatric Growth Hormone Deficiency market dynamics.
DelveInsight’s “Pediatric Growth Hormone Deficiency Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Pediatric Growth Hormone Deficiency, historical and forecasted epidemiology as well as the Pediatric Growth Hormone Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Pediatric Growth Hormone Deficiency Market Report:
- The Pediatric Growth Hormone Deficiency market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
- The FDA granted approval for the use of Skytrofa (lonapegsomatropin) in September 2021 for the treatment of pediatric patients aged one year and older who weigh at least 11.5 kg and have growth failure as a result of insufficient endogenous growth hormone secretion
- As per the study by Walter et al., the prevalence of GHD ranges between 1:3500 and 1:8700 in Germany
- As per the National Institute for Health and Clinical Excellence (NICE), the prevalence of growth hormone deficiency was estimated to be between 1 in 3500 and 1 in 4000 children
- In about half of the children with growth hormone deficiency (50%), the cause is unknown (idiopathic growth hormone deficiency)
- Key Pediatric Growth Hormone Deficiency Companies: OPKO Health, Lumos Pharma, Versartis Inc. , I-Mab Biopharma Co. Ltd., and others
- Key Pediatric Growth Hormone Deficiency Therapies: TJ101, NordiFlex, Somavaratan, MOD-4023, and others
Request a sample for the Pediatric Growth Hormone Deficiency Market Report
Key benefits of the Pediatric Growth Hormone Deficiency Market report:
- Pediatric Growth Hormone Deficiency market report covers a descriptive overview and comprehensive insight of the Pediatric Growth Hormone Deficiency Epidemiology and Pediatric Growth Hormone Deficiency market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Pediatric Growth Hormone Deficiency market report provides insights on the current and emerging therapies.
- Pediatric Growth Hormone Deficiency market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Pediatric Growth Hormone Deficiency market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Pediatric Growth Hormone Deficiency market.
Discover more about therapies set to grab major Pediatric Growth Hormone Deficiency market share @ Pediatric Growth Hormone Deficiency market forecast
Pediatric Growth Hormone Deficiency Overview
One of the various development problems that a kid may be born with or develop over time is growth hormone deficiency (GHD). It can happen by itself or along with widespread hypopituitarism. Although isolated GHD is typically idiopathic, roughly 25% of individuals have a known cause. Congenital reasons include specific CNS anomalies, abnormalities of the GH-releasing hormone receptor, and abnormalities of the GH1 gene. Acquired causes include meningitis, histiocytosis, brain damage, and therapeutic radiation of the CNS (high-dose radiation can result in global hypopituitarism). The development potential of the vertebrae may be further hampered by radiation to the spine, either preventatively or therapeutically, endangering height gain.
When the pituitary gland does not produce enough growth hormone, it results in paediatric growth hormone deficiency (PGHD). Damage to either the pituitary gland or the hypothalamus, another gland, may be the reason for it. The harm may develop congenitally, during labour, or after delivery (acquired). PGHD may be congenital (present from birth), acquired (due to brain tumours, head injuries, or other conditions), iatrogenic (caused by cancer therapy), or idiopathic (of unknown cause).
Pediatric Growth Hormone Deficiency Symptoms
The Pediatric Growth Hormone Deficiency symptoms include -
- A younger-looking face
- A chubby body build
- Impaired hair growth
- Delayed puberty
Pediatric Growth Hormone Deficiency Epidemiology Segmentation:
The Pediatric Growth Hormone Deficiency market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Total Prevalence of Pediatric Growth Hormone Deficiency
- Prevalent Cases of Pediatric Growth Hormone Deficiency by severity
- Gender-specific Prevalence of Pediatric Growth Hormone Deficiency
- Diagnosed Cases of Episodic and Chronic Pediatric Growth Hormone Deficiency
Pediatric Growth Hormone Deficiency Market
The dynamics of the Pediatric Growth Hormone Deficiency market are anticipated to change in the coming years owing to the expected launch of emerging therapies, and others during the forecasted period 2019-2032.
Download the report to understand which factors are driving Pediatric Growth Hormone Deficiency epidemiology trends @ Pediatric Growth Hormone Deficiency Epidemiological Insights
Pediatric Growth Hormone Deficiency Market Strengths
- Various approved therapies are available in the market for this condition which can help in successfully treating PGHD
- The emerging has some very potential treatments for PGHD
Pediatric Growth Hormone Deficiency Therapies
- TJ101
- NordiFlex
- Somavaratan
- MOD-4023
Pediatric Growth Hormone Deficiency Key Companies
- OPKO Health
- Lumos Pharma
- Versartis Inc.
- I-Mab
- Biopharma Co. Ltd.
Scope of the Pediatric Growth Hormone Deficiency Market Report
- Study Period: 2019–2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Pediatric Growth Hormone Deficiency Companies: OPKO Health, Lumos Pharma, Versartis Inc. , I-Mab Biopharma Co. Ltd., and others
- Key Pediatric Growth Hormone Deficiency Therapies: TJ101, NordiFlex, Somavaratan, MOD-4023, and others
- Therapeutic Assessment: Pediatric Growth Hormone Deficiency current marketed and Pediatric Growth Hormone Deficiency emerging therapies
- Migraine Market Dynamics: Pediatric Growth Hormone Deficiency market drivers and barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- Unmet Needs, KOL’s views, Analyst’s views, Pediatric Growth Hormone Deficiency Market Access and Reimbursement
Pediatric Growth Hormone Deficiency Market Opportunities
Since the emerging and approved treatments mainly comprise long-acting hGH, this is a major opportunity for companies to develop novel drugs with innovative mechanisms of action for PGHD which will give them an edge in the current market.
Table of Contents
1. Pediatric Growth Hormone Deficiency Market Report Introduction
2. Executive Summary for Pediatric Growth Hormone Deficiency
3. SWOT analysis of Pediatric Growth Hormone Deficiency
4. Pediatric Growth Hormone Deficiency Patient Share (%) Overview at a Glance
5. Pediatric Growth Hormone Deficiency Market Overview at a Glance
6. Pediatric Growth Hormone Deficiency Disease Background and Overview
7. Pediatric Growth Hormone Deficiency Epidemiology and Patient Population
8. Country-Specific Patient Population of Pediatric Growth Hormone Deficiency
9. Pediatric Growth Hormone Deficiency Current Treatment and Medical Practices
10. Pediatric Growth Hormone Deficiency Unmet Needs
11. Pediatric Growth Hormone Deficiency Emerging Therapies
12. Pediatric Growth Hormone Deficiency Market Outlook
13. Country-Wise Pediatric Growth Hormone Deficiency Market Analysis (2019–2032)
14. Pediatric Growth Hormone Deficiency Market Access and Reimbursement of Therapies
15. Pediatric Growth Hormone Deficiency Market drivers
16. Pediatric Growth Hormone Deficiency Market barriers
17. Pediatric Growth Hormone Deficiency Appendix
18. Pediatric Growth Hormone Deficiency Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
To know more about Pediatric Growth Hormone Deficiency treatment, visit @ Pediatric Growth Hormone Deficiency Medications
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
